News Headlines

  1. Medable AI Simplifies Trial Launch With Instant eCOA Generation 11/21/2024

    See the impact of AI’s new capabilities, such as automatically converting existing outcomes assessments into fully digital eCOAs in seconds and instantly generating scale assessments of varying complexity and logic.

  2. PCI Pharma Services And ChiRhoClin Partner To Prevent Shortage Of Critical Orphan Pancreatic Drug 11/19/2024

    PCI Pharma Services – (“PCI”) a leading global contract development and manufacturing organization (CDMO) focused on biopharma’s most complex therapies – is collaborating with theranostics specialist ChiRhoClin, Inc. to avoid the potential shortage of a critical diagnostic drug used to test for pancreatic disease and cancer. Following a high-priority

  3. Leading The Way: OpenClinica EDC Earns Major Recognition 11/18/2024
  4. Novotech Recognized For Excellence In Business Expansion, Innovation, And Marketing At The 2024 Clinical Trials Arena Excellence Awards 11/12/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO), has received multiple awards in the 2024 Clinical Trials Arena Excellence Awards, recognizing the achievements of our people in Business Expansion, Innovation, and Marketing. These awards highlight our commitment to advancing the clinical trial landscape and delivering specialized solutions across the biotech sector.

  5. Show Chwan Health Care System Joins Novotech To Accelerate The Quality Of International Clinical Trials Of New Drugs 11/12/2024

    Show Chwan Health Care System announced that it has signed a Memorandum of Understanding (MOU) with Novotech, a clinical research organization (CRO) in the Asia-Pacific region. It will use Novotech’s experience in planning clinical trials to target Changhua and the introduction of new clinical trial cases in Tainan, which will help doctors and patients get in touch with the latest treatment technologies and shorten the development period of new drugs.

  6. Avance Clinical CEO And Asia Director Sign MOUs With Key Clinical Trial Sites In Korea Around 2024 KoNECT 10/30/2024

    Avance Clinical, a leading full-service global Contract Research Organization (CRO) known for delivering high-quality, agile clinical research services, is proud to announce the signing of three significant Memorandums of Understanding (MOUs) with key Korean clinical sites during KoNECT 2024 conference.

  7. Signant Health And SPRIM PRO Align To Advance eClinical Solutions For Specialized Clinical Research 10/30/2024

    Signant Health, the leader in evidence generation for modern clinical trials, today announced a strategic alignment with SPRIM PRO, a boutique contract research organization (CRO) specializing in biopharmaceutical, nutrition, medical technology, and consumer health research. This collaboration combines Signant's innovative eClinical technology solution with SPRIM PRO's expertise in delivering digitally-enabled decentralized, hybrid, and onsite clinical trials.

  8. Everest Group Named Medable "Top Patient Engagement Trailblazer" 10/22/2024

    Medable was recognized as the “Top Patient Engagement Trailblazer” by the Everest Group. Learn how a combination of platform technologies built to engage patients landed them a 100% score.

  9. Join Avance Clinical At Biotech Showcase 2025 10/17/2024

    Avance Clinical, with over 30 years of experience as a leading full-service Contract Research Organization (CRO), is looking forward to once again meet with biotechs at Biotech Showcase 2025.

    With over 30 years of experience as a full-service Contract Research Organization (CRO) and known for our leading EARLY PHASE specialist clinical research in Australia, we are committed to delivering high-quality, compliant clinical trials.

  10. Join Avance Clinical At The CNS Summit 2024 10/17/2024

    Avance Clinical is thrilled to announce our participation in the CNS Summit 2024, taking place from November 10 – 13, 2024, in Boston, MA. The CNS Summit is a premier event dedicated to advancing clinical development and technology innovation in the Central Nervous System (CNS) therapeutic area. The Summit brings together a curated group of top decision makers from pharma, biotech, CROs, investigator sites, patient advocacy groups, investors and other stakeholders.